Long-term virological suppression on first-line efavirenz + tenofovir + emtricitabine/lamivudine for HIV-1. (2019)

First Author: Long-Term Virological Suppression Working Group For The Collaboration Of Observational HIV Epidemiological Research Europe (COHERE) In EuroCoord

Attributed to: Prognosis of HIV-positive patients treated with antiretroviral therapy: comparative analyses and treatment strategies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/qad.0000000000002126

PubMed Identifier: 30829745

Publication URI: http://europepmc.org/abstract/MED/30829745

Type: Journal Article/Review

Volume: 33

Parent Publication: AIDS (London, England)

Issue: 4

ISSN: 0269-9370